Antonio G.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase 3 Study of Lisaftoclax (APG-2575) and Acalabrutinib in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients
- Evaluation of Copper Cu 64 PSMA I&T PET/CT for Detecting Pelvic Lymph Node Metastasis in High-Risk Prostate Cancer Pre-Prostatectomy Patients
- Evaluation of Chemotherapy with Nivolumab in Early-Stage Classical Hodgkin Lymphoma with Low Metabolic Tumor Volume and Negative Interim PET
Data & Insights
Has run more than one trial at 43 of 156 partner sites.
Specializations
Lymphoma Research Focus
Specializes in investigating novel treatments for various types of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. The investigator studies innovative therapeutic approaches including immunotherapy and targeted treatments.
- Advanced stage follicular lymphoma management
- DLBCL treatment optimization
- Mantle cell lymphoma interventions
Leukemia Studies
Focuses on developing treatments for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Investigates combination therapies using novel agents and established treatments to improve patient outcomes.
- Novel therapeutic combinations
- Treatment strategies for previously treated patients
- Targeted therapy approaches
Innovative Treatment Approaches
Explores cutting-edge therapeutic strategies including BTK inhibitors, monoclonal antibodies, and cellular therapies. The investigator evaluates radiation-free treatment options and response-adapted approaches in lymphoid malignancies.
- Chemotherapy-free regimens
- Response-guided therapy
- Early-stage disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.